COVID-19 cases have recently increased in Europe, with the delta variant rapidly spreading across the region even in the context of good vaccination levels. Given the increase in cases, we think testing will continue to be important as the vaccines aren’t 100% effective and there is always the risk of vaccine escape variants. Following the rapid development of a COVID-19 diagnostic tests (a validation of the Bio-Medical investment strategy, in our view) BATM has continued to innovate and has dev ....
